BENTLEY, AUSTRALIA – February 4th 2022 – SynGenis Pty Ltd received a small business grant from the Town of Victoria Park to showcase Biotechnology Businesses in Bentley Technology Park. “SynGenis has been awarded a grant from Victoria Park Council to organise a Biotech trail event together with Epichem, Gene S and Xytovet, and we are […]
PERTH, AUSTRALIA, 3 November 2021: – Medical technology start-up SynGenis Pty Ltd today announced it has received $50,000 under the MTP Manufacturing Voucher Program. The Perth-based business makes the raw materials needed for polymerase chain reaction (PCR) Covid-19 tests and the funds will enable SynGenis to deliver ISO 9001:2015 and GMP certified products to the […]
Our recent partnership with SpeeDx was featured in the West Australian and highlights the importance of sovereign capabilities for Australia. Read the full article.
SynGenis announced a partnership with SpeeDx Pty Ltd., a developer of innovative molecular diagnostic solutions. The partnership will support the expansion of SynGenis to provide reliable, high quality large-scale oligonucleotides and bolster internal capacity of SpeeDx to support large-scale increases in manufacturing while developing and expanding sovereign capacity of important raw materials used in molecular […]
SynGenis Pty Ltd was officially opened today by our wonderful Western Australia chief scientist Peter Klinken. Peter together with the other delegates including our founder Rakesh Veedu, chairman Steve Arnott and industry representatives James Williams and Kevin Pfleger toured the facilities and found out about our history.